Bavarian Nordic A/S (BVNRY)
11.04
-0.12
(-1.03%)
USD |
OTCM |
Sep 25, 16:00
Bavarian Nordic Cash from Operations (Annual) : 411.60M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 411.60M |
| December 31, 2024 | 282.77M |
| December 31, 2023 | 162.39M |
| December 31, 2022 | 31.09M |
| December 31, 2021 | -56.98M |
| December 31, 2020 | 87.46M |
| December 31, 2019 | -41.36M |
| December 31, 2018 | -45.67M |
| December 31, 2017 | 32.76M |
| December 31, 2016 | 39.76M |
| December 31, 2015 | 15.66M |
| December 31, 2014 | 60.28M |
| December 31, 2013 | 26.18M |
| December 31, 2012 | 3.468M |
| Date | Value |
|---|---|
| December 31, 2011 | -70.04M |
| December 31, 2010 | -42.62M |
| December 31, 2009 | -90.40M |
| December 31, 2008 | -4.398M |
| December 31, 2007 | 29.98M |
| December 31, 2006 | -32.66M |
| December 31, 2005 | -9.702M |
| December 31, 2004 | -12.85M |
| December 31, 2003 | 31.83M |
| December 31, 2002 | -1.74M |
| December 31, 2001 | -11.18M |
| December 31, 2000 | -9.219M |
| December 31, 1999 | -8.799M |
| December 31, 1998 | -5.424M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Evaxion AS | -6.645M |
| Genmab A/S | 1.190B |
| Ascendis Pharma A/S | 60.83M |
| Zealand Pharma A/S | 987.74M |
| Agenus, Inc. | -77.20M |